By structuring a business model for its investment projects, by investing its financial resources and attracting the resources of private investors to its projects, RUSNANO is helping to transform scientific developments with commercial potential into full-fledged businesses that will improve the economy of the country and contribute to better lives on the planet.
Fostering a New Industry
– Technically feasible
– Comercially viable
– Nanotech related
– Russia based
– Sales of $8.5 million
The company invests in a wide array of projects: alternative energy, biomedicine, new materials, mechanical engineering, and metalwork to name a few. For entrepreneurs with the right ideas and the skills and vision to carry them through, funding is available to manufacture new products or to broaden and modernize existing production. In order for a proposed project to win approval for co-investment, it must meet several criteria:
- Technical feasibility and economic viability
- Offer a product or products directly related to nanotechnology
- Willingness to locate manufacturing and/or R&D center in Russia
- Reliably forecasted sales of 250 million rubles ($8.5 million) or more within five years from initiation
RUSNANO employs various forms of investment with its portfolio companies: investment in owners’ equity, loans, credit guarantees, and leasing operations. Part of project costs must be privately financed through owners’ equity and other investment mechanisms.
RUSNANO’s system for selecting projects encompasses analysis of the competitiveness of proposed products in Russian and global markets. Many projects approved for co-investment have developed proprietary technology to produce products at the world-class level.
Here are only a few examples of the innovative projects of RUSNANO’s portfolio companies, offering products that surpass global analogues on technical, economic, and consumer characteristics.
RUSNANO’s mission is to build a competitive nanotechnology industry based on the advances of Russian scientists and the transfer of cutting-edge technologies from other countries.
- Vaccines based on virus-like particles. Incapable of reproduction, the particles serve as containers for delivering genes of proteins that induce a desired immune response. Technology for the vaccines was developed at the Gamaleya Institute of Epidemiology and Microbiology, the Research Institute of Influenza, and other leading research institutes in Russia.
- Magnetoresistive random access memory based on Thermally Assisted Switching™ developed by Crocus Technology. TAS MRAM offers unlimited endurance, non-volatility, and fast read/write performance, combining benefits of well-established semiconductor memories, such as DRAM, SRAM, and Flash without their limitations. Crocus has gone beyond establishing production in Russia. The company plans to invest up to $5 million in Russian research organizations that will refine the technology.
- Detectors of explosives and illicit substances using tagged neutron technology developed at the Joint Institute for Nuclear Research. The detectors, which come in forms for scanning luggage, vehicles, and cargo containers, work by identifying the elemental composition of substances, not by the usual density scanning of X-ray technology. Detectors that use tagged neutrons have been placed in metro and railway stations as part of a Russian federal program for transportation safety.